Current Ratio of Lyell Immunopharma, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Lyell Immunopharma, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2022 to 30 Sep 2025.
  • Lyell Immunopharma, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 793%, a 49% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Lyell Immunopharma, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 793% -760% -49% 30 Sep 2025
Q2 2025 859% -779% -48% 30 Jun 2025
Q1 2025 1028% -646% -39% 31 Mar 2025
Q4 2024 1238% -522% -30% 31 Dec 2024
Q3 2024 1553% -245% -14% 30 Sep 2024
Q2 2024 1638% -19% -1.1% 30 Jun 2024
Q1 2024 1674% +137% +8.9% 31 Mar 2024
Q4 2023 1760% +311% +21% 31 Dec 2023
Q3 2023 1799% +436% +32% 30 Sep 2023
Q2 2023 1657% +365% +28% 30 Jun 2023
Q1 2023 1537% +247% +19% 31 Mar 2023
Q4 2022 1450% 31 Dec 2022
Q3 2022 1362% 30 Sep 2022
Q2 2022 1292% 30 Jun 2022
Q1 2022 1290% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.